Wegovy pill sales lift Novo's profit and its outlook
Third-quarter sales rose 4% to $11.9 billion, beating forecasts, and shares rose as much as 6%. Chief executive Mike Doustdar said Novo still has 80% of the market.
Where this came from. 2 outlets reported this. We read them, then wrote the sixty words above.